Skip to main content

Advertisement

Table 2 Correlation between variations in body composition and psychiatric symptoms after intragastric balloon (IGB) treatment (∆ for all variables)

From: Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

  BMI (kg/m2) Weight (kg) Waist (cm) Total fat (g) Total fat (%) Lean mass (g)
BDI r = 0.11 p = 0.48 r = 0.12 p = 0.46 r = 0.24 p = 0.14 r = 0.20 p = 0.26 r = 0.46 p = 0.008 r = −0.04 p = 0.81
HADS-depression r = 0.02 p = 0.87 r = 0.05 p = 0.75 r = 0.23 p = 0.16 r = −0.02 p = 0.89 r = 0.12 p = 0.50 r = 0.05 p = 0.77
HADS-anxiety r = 0.27 p = 0.084 r = 0.28 p = 0.08 r = 0.38 p = 0.017 r = 0.21 p = 0.22 r = 0.42 p = 0.014 r = 0.22 p = 0.21
  1. DXA dual-energy X-ray absorptiometry; BMI body mass index; BDI Beck Depression Inventory; HADS hospital anxiety and depression scale; HADS-D hospital anxiety and depression scale-depression; HADS-A hospital anxiety and depression scale-anxiety